drughunter.com
< 1 minute read
Sep. 18, 2021

LXE408: A Kinetoplastid-Selective Proteasome Inhibitor

LXE408

kinetoplastid-selective proteasome inhibitor oral antileishmanial in Ph. I in HV From 3M cmpd antiprolif. screen + opt. J. Med. Chem., Jul. 29, 2020 Novartis (GNF), San Diego, CA

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in